Paroma Arefin | Pharmaceutical Science | Women Researcher Award

Published on by Academic Achievements

Women Researcher Award

Paroma Arefin
Affiliation University of Houston
Country United States
Scopus ID 57041256700
Documents 15
Citations 67
h-index 6
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Achievements & Awards
ORCID 0000-0002-5968-1002

Paroma Arefin

Institution: University of Houston, United States

Paroma Arefin is a researcher whose scholarly work spans pharmaceutical sciences, proton exchange membrane fuel cells, hydrogen energy technologies, biomaterials, and public health research. Her interdisciplinary publications demonstrate contributions to pharmaceutical formulation, sustainable energy systems, healthcare technologies, and consumer health awareness. Through peer-reviewed research, she has participated in studies addressing fuel cell durability, drug delivery systems, mobility assistance technologies, and healthcare education, reflecting an interdisciplinary approach that bridges engineering and pharmaceutical sciences.[1]

Abstract

This article summarizes the academic profile and research achievements of Paroma Arefin in recognition of the Women Researcher Award. Her publications primarily address proton exchange membrane fuel cells, hydrogen-powered transportation, pharmaceutical formulation, biomaterials, and healthcare studies. These contributions demonstrate interdisciplinary scholarship that combines pharmaceutical sciences with emerging sustainable energy technologies and applied healthcare research. Her publication record, citation profile, and collaborative research activities illustrate continued participation in internationally visible scientific literature.[1][2]

Keywords

Women Researcher Award, Paroma Arefin, Pharmaceutical Science, Proton Exchange Membrane Fuel Cell, Hydrogen Energy, Drug Delivery, Biomaterials, Fuel Cell Durability, Healthcare Research, University of Houston.

Introduction

Interdisciplinary scientific research increasingly contributes to addressing global healthcare and energy challenges. Paroma Arefin’s scholarly work reflects this trend through publications involving pharmaceutical formulations, hydrogen fuel cell technology, mobility assistance devices, and public health awareness. Her research integrates engineering concepts with pharmaceutical sciences to explore practical solutions that may contribute to healthcare innovation and sustainable energy development.[2]

Research Profile

  • Affiliation: University of Houston.
  • Research specialization includes Pharmacology, Toxicology and Pharmaceutical Science.
  • Scopus Author ID: 57041256700.
  • Research output includes interdisciplinary studies in pharmaceutical sciences, hydrogen fuel cells and healthcare.
  • Publication metrics include 15 indexed documents, 67 citations and an h-index of 6.

Research Contributions

Paroma Arefin has co-authored review articles examining durability factors affecting proton exchange membrane fuel cells, including the influence of operating temperature and membrane degradation mechanisms. These studies provide comprehensive overviews of hydrogen fuel cell technologies and summarize engineering challenges affecting long-term performance.[3]

Her pharmaceutical research includes formulation and characterization of controlled-release microspheres containing Fexofenadine hydrochloride, contributing to studies on drug delivery systems and controlled pharmaceutical release technologies.[4]

Additional publications address consumer awareness regarding food adulteration, mobility assistive devices for elderly populations, and hydrogen-powered transportation systems, demonstrating broad interdisciplinary engagement across engineering and health sciences.[5]

Publications

  • Effect of temperature on the performance factors and durability of proton exchange membrane of hydrogen fuel cell: A narrative review (2020).
  • Proton exchange membrane fuel cell durability factors, challenges, and future perspectives: A detailed review (2021).
  • Study on awareness about food adulteration and consumer rights among consumers in Dhaka, Bangladesh (2020).
  • Adoption of hydrogen fuel cell vehicles and its prospects for the future: A review (2022).
  • Design, characterization and in vitro evaluation of HPMC K100 M CR loaded Fexofenadine HCl microspheres (2016).
  • A comparison of mobility assistive devices for elderly and patients with lower limb injury: Narrative Review.

Research Impact

Citation indicators demonstrate measurable academic visibility within pharmaceutical science and hydrogen energy research. Review articles concerning proton exchange membrane fuel cells have contributed to knowledge synthesis in sustainable energy technologies, while pharmaceutical formulation studies support advances in controlled drug delivery. Collectively, these works reflect interdisciplinary collaboration and continued scholarly engagement across multiple research domains.[1][3]

Award Suitability

Based on her documented publication record, interdisciplinary collaborations, citation profile, and research contributions spanning pharmaceutical sciences, hydrogen fuel cell technologies, healthcare applications, and public health, Paroma Arefin demonstrates characteristics consistent with recognition through the Women Researcher Award. Her research portfolio illustrates continued scholarly activity, international collaboration, and contributions to scientific literature relevant to sustainable technologies and pharmaceutical innovation.[1]

Conclusion

Paroma Arefin’s academic record demonstrates interdisciplinary scholarship across pharmaceutical science, sustainable energy technologies, healthcare engineering, and biomedical research. Her publications, citation metrics, and collaborative research activities collectively represent meaningful contributions to contemporary scientific literature. The combination of pharmaceutical innovation and engineering-focused sustainability research supports her recognition within international academic award programs.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Paroma Arefin, Author ID 57041256700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57041256700
  2. Salam, M. A., Habib, M. S., Arefin, P., Ahmed, K., Uddin, S., Hossain, T., & Papri, N. (2020).
    Effect of Temperature on the Performance Factors and Durability of Proton Exchange Membrane of Hydrogen Fuel Cell: A Narrative Review.
    Material Science Research India, 17(2), 179–191.
    DOI: https://doi.org/10.13005/msri/170207
  3. Habib, M. S., Arefin, P., Salam, M. A., Ahmed, K., Uddin, M. S., Hossain, T., Papri, N., et al. (2021). Proton Exchange Membrane Fuel Cell (PEMFC) Durability Factors, Challenges, and Future Perspectives: A Detailed Review.
    Material Science Research India, 18(2), 217–234.
    DOI: https://doi.org/10.13005/msri/180209
  4. Arefin, P., Hasan, I., & Reza, M. S. (2016).
    Design, Characterization and In Vitro Evaluation of HPMC K100 M CR Loaded Fexofenadine HCl Microspheres.  SpringerPlus, 5, 691. DOI: https://doi.org/10.1186/s40064-016-2322-2
  5. Habib, M. S., & Arefin, P. (2022).
    Adoption of Hydrogen Fuel Cell Vehicles and Its Prospects for the Future (A Review).
    Oriental Journal of Chemistry, 38(3), 621–631. DOI: https://doi.org/10.13005/ojc/380311

Ume Ruqia Tulain| Pharmaceutics | Best Researcher Award

Published on by Academic Achievements

Ume Ruqia Tulain| Pharmaceutics | Best Researcher Award

Dr. Ume Ruqia Tulain| Pharmaceutics |Assistant Professor at University of Sargodha , Pakistan

Dr. Ume Ruqia Tulain is an Assistant Professor at the Faculty of Pharmacy, University of Sargodha, Pakistan. With over 15 years of teaching and research experience, she specializes in pharmaceutics, focusing on controlled drug delivery systems. She holds a PhD in Pharmaceutics from The Islamia University of Bahawalpur. Dr. Tulain has published numerous papers in renowned international journals, and her research is recognized globally for its contributions to drug delivery technologies. She has actively participated in multiple national and international conferences, workshops, and seminars, contributing significantly to the pharmaceutical sciences community.

Professional Profile

Google Scholar

Scopus

Education

Dr. Ume Ruqia Tulain earned her B-Pharm, M.Phil, and PhD degrees from The Islamia University of Bahawalpur, Pakistan, completing her education with top distinctions. She completed her Matriculation and F.Sc from BISE Sargodha, achieving first divisions. Her academic journey reflects a strong foundation in pharmacy and a commitment to advancing the field of pharmaceutics.

Experience

Dr. Tulain has been an integral part of the Faculty of Pharmacy at the University of Sargodha since 2008, where she has held the roles of Lecturer and Assistant Professor. She has taught a wide array of subjects including Pharmaceutical Quality Management, Dosage Form Design, and Pharmaceutical Microbiology to both undergraduate and postgraduate students. Dr. Tulain also supervises M.Phil and PhD students and has served as an external examiner and reviewer for several international journals. She has been involved in various administrative committees at the university level as well.

Research Interests

Dr. Tulain’s research focuses on the development of controlled drug delivery systems using graft copolymers, hydrogels, microspheres, and nanoparticles as drug carriers. Her work is aimed at improving the efficacy and safety of pharmaceutical formulations. She has conducted significant research in oral controlled drug delivery and formulation development, with a special interest in the in vitro and in vivo evaluation of novel drug carriers.

Awards

Dr. Tulain has received multiple awards for her outstanding research contributions. In 2022 and 2023, she was honored with the “Research Award in recognition of outstanding research publication” for her prolific work in pharmaceutical sciences. Additionally, her research projects have garnered attention, including the successful co-investigation of a project on controlled drug delivery systems. She was also a recipient of the “Best Researcher” award at the University of Sargodha.

Publications

Nigella sativa (Prophetic Medicine): A Review

Citations: 131

Lactic acid bacteria in traditional fermented Asian foods

Citations: 78

Preparation and characterization of pH sensitive crosslinked Linseed polysaccharides-co-acrylic acid/methacrylic acid hydrogels for controlled delivery of ketoprofen

Citations: 51

Fabrication of Ph‐responsive hydrogel and its in vitro and in vivo evaluation

Citations: 50

β-cyclodextrin chitosan-based hydrogels with tunable pH-responsive properties for controlled release of acyclovir: design, characterization, safety, and pharmacokinetic evaluation

Citations: 42

Acute toxicity studies of a novel excipient arabinoxylan isolated from Ispaghula (Plantago ovata) husk

Citations: 39

Thiolation of arabinoxylan and its application in the fabrication of pH-sensitive thiolated arabinoxylan grafted acrylic acid copolymer

Citations: 35

Design and in vitro evaluation of pH-sensitive crosslinked chitosan-grafted acrylic acid copolymer (CS-co-AA) for targeted drug delivery

Citations: 33

pH sensitive pluronic acid/agarose-hydrogels as controlled drug delivery carriers: design, characterization and toxicity evaluation

Citations: 26

Microwave radiation induced synthesis of hydroxypropyl methylcellulose-graft-(polyvinylalcohal-co-acrylic acid) polymeric network and its in vitro evaluation

Citations: 24

 

Conclusion

Dr. Tulain’s exceptional research output, coupled with her commitment to advancing pharmaceutical sciences and fostering academic excellence, positions her as an outstanding candidate for the “Best Researcher Award.” Her consistent contributions, coupled with her leadership in the research community, make her an excellent role model and deserving of this recognition.